ArticleSurgery today2018
Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.
Hiroshi Wada et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it